nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Desmopressin—AVPR1A—coronary artery disease	0.00638	0.889	CrCbGaD
Nafarelin—Desmopressin—PTGS2—coronary artery disease	0.000798	0.111	CrCbGaD
Nafarelin—GNRHR—Signaling by GPCR—PPBP—coronary artery disease	0.000587	0.00198	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—KNG1—coronary artery disease	0.000577	0.00194	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—AGTR1—coronary artery disease	0.000573	0.00193	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—AVPR1A—coronary artery disease	0.000569	0.00192	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ADM2—coronary artery disease	0.000568	0.00191	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCL10—coronary artery disease	0.00056	0.00189	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—OPRD1—coronary artery disease	0.00056	0.00189	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL4—coronary artery disease	0.00056	0.00189	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—coronary artery disease	0.000558	0.00188	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—C3—coronary artery disease	0.000558	0.00188	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—UTS2—coronary artery disease	0.00055	0.00185	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—ADRB2—coronary artery disease	0.000544	0.00183	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TMED2—coronary artery disease	0.000538	0.00181	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PLCB3—coronary artery disease	0.000532	0.00179	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—P2RY12—coronary artery disease	0.000532	0.00179	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—coronary artery disease	0.00053	0.00179	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CASR—coronary artery disease	0.000527	0.00178	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AVPR1A—coronary artery disease	0.000517	0.00174	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—BDKRB1—coronary artery disease	0.000517	0.00174	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GNA12—coronary artery disease	0.000517	0.00174	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—LRP8—coronary artery disease	0.000514	0.00173	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—DGKZ—coronary artery disease	0.000514	0.00173	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RLN3—coronary artery disease	0.000514	0.00173	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—coronary artery disease	0.00051	0.00172	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ADM—coronary artery disease	0.000503	0.00169	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—UTS2—coronary artery disease	0.000499	0.00168	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AES—coronary artery disease	0.000492	0.00166	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—EDN2—coronary artery disease	0.000492	0.00166	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PDE4B—coronary artery disease	0.00049	0.00165	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2—coronary artery disease	0.00049	0.00165	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—EDN1—coronary artery disease	0.000486	0.00164	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PLCB3—coronary artery disease	0.000484	0.00163	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—P2RY12—coronary artery disease	0.000484	0.00163	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL5—coronary artery disease	0.000482	0.00163	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CX3CR1—coronary artery disease	0.000479	0.00161	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CASR—coronary artery disease	0.000479	0.00161	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HRH2—coronary artery disease	0.000474	0.0016	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—BDKRB1—coronary artery disease	0.000469	0.00158	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CX3CL1—coronary artery disease	0.000469	0.00158	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GNA12—coronary artery disease	0.000469	0.00158	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PPP3R1—coronary artery disease	0.000461	0.00155	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ADM—coronary artery disease	0.000457	0.00154	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR3—coronary artery disease	0.000448	0.00151	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—coronary artery disease	0.000446	0.0015	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PDE4B—coronary artery disease	0.000445	0.0015	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—coronary artery disease	0.000436	0.00147	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ACVR1B—coronary artery disease	0.00043	0.00145	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RHOC—coronary artery disease	0.00043	0.00145	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—HTR2A—coronary artery disease	0.000425	0.00143	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—C3—coronary artery disease	0.000425	0.00143	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL2—coronary artery disease	0.000421	0.00142	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NEDD4—coronary artery disease	0.000419	0.00141	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—F2R—coronary artery disease	0.000417	0.0014	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PF4—coronary artery disease	0.000408	0.00137	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RAMP2—coronary artery disease	0.000408	0.00137	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PDE3A—coronary artery disease	0.000408	0.00137	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MDK—coronary artery disease	0.000408	0.00137	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR3—coronary artery disease	0.000407	0.00137	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—EDNRB—coronary artery disease	0.000404	0.00136	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—AGT—coronary artery disease	0.000403	0.00136	CbGpPWpGaD
Nafarelin—Insomnia—Perindopril—coronary artery disease	0.000395	0.000567	CcSEcCtD
Nafarelin—Diarrhoea—Clopidogrel—coronary artery disease	0.000395	0.000567	CcSEcCtD
Nafarelin—Asthenia—Eplerenone—coronary artery disease	0.000395	0.000567	CcSEcCtD
Nafarelin—Mental disorder—Lisinopril—coronary artery disease	0.000393	0.000564	CcSEcCtD
Nafarelin—Diarrhoea—Lovastatin—coronary artery disease	0.000392	0.000563	CcSEcCtD
Nafarelin—Paraesthesia—Perindopril—coronary artery disease	0.000392	0.000563	CcSEcCtD
Nafarelin—Urticaria—Niacin—coronary artery disease	0.000391	0.000562	CcSEcCtD
Nafarelin—Decreased appetite—Captopril—coronary artery disease	0.000391	0.000561	CcSEcCtD
Nafarelin—Anorexia—Losartan—coronary artery disease	0.00039	0.000561	CcSEcCtD
Nafarelin—Nausea—Acetylsalicylic acid—coronary artery disease	0.00039	0.000561	CcSEcCtD
Nafarelin—Malnutrition—Lisinopril—coronary artery disease	0.00039	0.00056	CcSEcCtD
Nafarelin—Pruritus—Eplerenone—coronary artery disease	0.000389	0.000559	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—F2RL1—coronary artery disease	0.000389	0.00131	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NPY5R—coronary artery disease	0.000389	0.00131	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RALBP1—coronary artery disease	0.000389	0.00131	CbGpPWpGaD
Nafarelin—Dyspnoea—Perindopril—coronary artery disease	0.000389	0.000559	CcSEcCtD
Nafarelin—Dizziness—Fenofibrate—coronary artery disease	0.000388	0.000558	CcSEcCtD
Nafarelin—Vertigo—Ramipril—coronary artery disease	0.000386	0.000555	CcSEcCtD
Nafarelin—Urticaria—Pravastatin—coronary artery disease	0.000385	0.000553	CcSEcCtD
Nafarelin—Asthenia—Simvastatin—coronary artery disease	0.000385	0.000553	CcSEcCtD
Nafarelin—Diarrhoea—Ezetimibe—coronary artery disease	0.000385	0.000553	CcSEcCtD
Nafarelin—Constipation—Captopril—coronary artery disease	0.000384	0.000552	CcSEcCtD
Nafarelin—Tension—Lisinopril—coronary artery disease	0.000383	0.00055	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CXCL2—coronary artery disease	0.000383	0.00129	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL3—coronary artery disease	0.000383	0.00129	CbGpPWpGaD
Nafarelin—Dysgeusia—Lisinopril—coronary artery disease	0.000382	0.000549	CcSEcCtD
Nafarelin—Dizziness—Clopidogrel—coronary artery disease	0.000382	0.000548	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—EDNRA—coronary artery disease	0.000381	0.00128	CbGpPWpGaD
Nafarelin—Paraesthesia—Furosemide—coronary artery disease	0.000381	0.000547	CcSEcCtD
Nafarelin—Palpitations—Ramipril—coronary artery disease	0.00038	0.000546	CcSEcCtD
Nafarelin—Decreased appetite—Perindopril—coronary artery disease	0.000379	0.000545	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—ADRB1—coronary artery disease	0.000379	0.00128	CbGpPWpGaD
Nafarelin—Pruritus—Simvastatin—coronary artery disease	0.000379	0.000545	CcSEcCtD
Nafarelin—Dizziness—Lovastatin—coronary artery disease	0.000379	0.000544	CcSEcCtD
Nafarelin—Nervousness—Lisinopril—coronary artery disease	0.000379	0.000544	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—F2R—coronary artery disease	0.000378	0.00128	CbGpPWpGaD
Nafarelin—Vertigo—Timolol—coronary artery disease	0.000378	0.000543	CcSEcCtD
Nafarelin—Diarrhoea—Eplerenone—coronary artery disease	0.000376	0.000541	CcSEcCtD
Nafarelin—Urticaria—Trandolapril—coronary artery disease	0.000374	0.000537	CcSEcCtD
Nafarelin—Constipation—Perindopril—coronary artery disease	0.000373	0.000536	CcSEcCtD
Nafarelin—Vomiting—Fenofibrate—coronary artery disease	0.000373	0.000536	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—FZD2—coronary artery disease	0.000373	0.00126	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—UTS2R—coronary artery disease	0.000373	0.00126	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000373	0.000536	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—F2—coronary artery disease	0.000373	0.00126	CbGpPWpGaD
Nafarelin—Convulsion—Ramipril—coronary artery disease	0.000373	0.000535	CcSEcCtD
Nafarelin—Urticaria—Enalapril—coronary artery disease	0.000372	0.000535	CcSEcCtD
Nafarelin—Dizziness—Ezetimibe—coronary artery disease	0.000372	0.000534	CcSEcCtD
Nafarelin—Palpitations—Timolol—coronary artery disease	0.000372	0.000534	CcSEcCtD
Nafarelin—Insomnia—Losartan—coronary artery disease	0.00037	0.000532	CcSEcCtD
Nafarelin—Rash—Fenofibrate—coronary artery disease	0.00037	0.000532	CcSEcCtD
Nafarelin—Dermatitis—Fenofibrate—coronary artery disease	0.00037	0.000531	CcSEcCtD
Nafarelin—Decreased appetite—Furosemide—coronary artery disease	0.000369	0.00053	CcSEcCtD
Nafarelin—Headache—Fenofibrate—coronary artery disease	0.000368	0.000528	CcSEcCtD
Nafarelin—Paraesthesia—Losartan—coronary artery disease	0.000368	0.000528	CcSEcCtD
Nafarelin—Urticaria—Telmisartan—coronary artery disease	0.000367	0.000528	CcSEcCtD
Nafarelin—Vomiting—Clopidogrel—coronary artery disease	0.000367	0.000527	CcSEcCtD
Nafarelin—Diarrhoea—Simvastatin—coronary artery disease	0.000367	0.000527	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—EDNRB—coronary artery disease	0.000366	0.00123	CbGpPWpGaD
Nafarelin—Arthralgia—Ramipril—coronary artery disease	0.000366	0.000526	CcSEcCtD
Nafarelin—Myalgia—Ramipril—coronary artery disease	0.000366	0.000526	CcSEcCtD
Nafarelin—Chest pain—Ramipril—coronary artery disease	0.000366	0.000526	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—SFRP2—coronary artery disease	0.000366	0.00123	CbGpPWpGaD
Nafarelin—Dyspnoea—Losartan—coronary artery disease	0.000365	0.000524	CcSEcCtD
Nafarelin—Vomiting—Lovastatin—coronary artery disease	0.000364	0.000523	CcSEcCtD
Nafarelin—Dizziness—Eplerenone—coronary artery disease	0.000364	0.000523	CcSEcCtD
Nafarelin—Rash—Clopidogrel—coronary artery disease	0.000364	0.000523	CcSEcCtD
Nafarelin—Dermatitis—Clopidogrel—coronary artery disease	0.000363	0.000522	CcSEcCtD
Nafarelin—Asthenia—Valsartan—coronary artery disease	0.000363	0.000522	CcSEcCtD
Nafarelin—Constipation—Furosemide—coronary artery disease	0.000363	0.000521	CcSEcCtD
Nafarelin—Asthenia—Olmesartan—coronary artery disease	0.000361	0.000519	CcSEcCtD
Nafarelin—Headache—Clopidogrel—coronary artery disease	0.000361	0.000519	CcSEcCtD
Nafarelin—Rash—Lovastatin—coronary artery disease	0.000361	0.000519	CcSEcCtD
Nafarelin—Dermatitis—Lovastatin—coronary artery disease	0.000361	0.000519	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—ADORA1—coronary artery disease	0.000359	0.00121	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ADORA3—coronary artery disease	0.000359	0.00121	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOA4—coronary artery disease	0.000359	0.00121	CbGpPWpGaD
Nafarelin—Headache—Lovastatin—coronary artery disease	0.000359	0.000516	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—BDKRB2—coronary artery disease	0.000358	0.00121	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL12—coronary artery disease	0.000358	0.00121	CbGpPWpGaD
Nafarelin—Pruritus—Valsartan—coronary artery disease	0.000358	0.000515	CcSEcCtD
Nafarelin—Arthralgia—Timolol—coronary artery disease	0.000358	0.000514	CcSEcCtD
Nafarelin—Chest pain—Timolol—coronary artery disease	0.000358	0.000514	CcSEcCtD
Nafarelin—Myalgia—Timolol—coronary artery disease	0.000358	0.000514	CcSEcCtD
Nafarelin—Vomiting—Ezetimibe—coronary artery disease	0.000357	0.000513	CcSEcCtD
Nafarelin—Pruritus—Olmesartan—coronary artery disease	0.000356	0.000512	CcSEcCtD
Nafarelin—Decreased appetite—Losartan—coronary artery disease	0.000356	0.000511	CcSEcCtD
Nafarelin—Dizziness—Simvastatin—coronary artery disease	0.000354	0.000509	CcSEcCtD
Nafarelin—Rash—Ezetimibe—coronary artery disease	0.000354	0.000509	CcSEcCtD
Nafarelin—Dermatitis—Ezetimibe—coronary artery disease	0.000354	0.000509	CcSEcCtD
Nafarelin—Asthenia—Niacin—coronary artery disease	0.000353	0.000507	CcSEcCtD
Nafarelin—Headache—Ezetimibe—coronary artery disease	0.000352	0.000506	CcSEcCtD
Nafarelin—Oedema—Ramipril—coronary artery disease	0.000351	0.000504	CcSEcCtD
Nafarelin—Vertigo—Lisinopril—coronary artery disease	0.00035	0.000504	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—PLCB1—coronary artery disease	0.00035	0.00118	CbGpPWpGaD
Nafarelin—Constipation—Losartan—coronary artery disease	0.00035	0.000503	CcSEcCtD
Nafarelin—Vomiting—Eplerenone—coronary artery disease	0.00035	0.000503	CcSEcCtD
Nafarelin—Nausea—Fenofibrate—coronary artery disease	0.000349	0.000501	CcSEcCtD
Nafarelin—Pruritus—Niacin—coronary artery disease	0.000348	0.0005	CcSEcCtD
Nafarelin—Asthenia—Pravastatin—coronary artery disease	0.000348	0.0005	CcSEcCtD
Nafarelin—Rash—Eplerenone—coronary artery disease	0.000347	0.000498	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PPBP—coronary artery disease	0.000347	0.00117	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PGF—coronary artery disease	0.000347	0.00117	CbGpPWpGaD
Nafarelin—Urticaria—Perindopril—coronary artery disease	0.000347	0.000498	CcSEcCtD
Nafarelin—Dermatitis—Eplerenone—coronary artery disease	0.000347	0.000498	CcSEcCtD
Nafarelin—Diarrhoea—Valsartan—coronary artery disease	0.000346	0.000498	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—EDNRA—coronary artery disease	0.000346	0.00117	CbGpPWpGaD
Nafarelin—Shock—Ramipril—coronary artery disease	0.000345	0.000496	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	0.000345	0.00116	CbGpPWpGaD
Nafarelin—Palpitations—Lisinopril—coronary artery disease	0.000345	0.000495	CcSEcCtD
Nafarelin—Diarrhoea—Olmesartan—coronary artery disease	0.000345	0.000495	CcSEcCtD
Nafarelin—Headache—Eplerenone—coronary artery disease	0.000345	0.000495	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—ADRB1—coronary artery disease	0.000345	0.00116	CbGpPWpGaD
Nafarelin—Oedema—Timolol—coronary artery disease	0.000343	0.000493	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—HTR7—coronary artery disease	0.000343	0.00116	CbGpPWpGaD
Nafarelin—Pruritus—Pravastatin—coronary artery disease	0.000343	0.000493	CcSEcCtD
Nafarelin—Nausea—Clopidogrel—coronary artery disease	0.000343	0.000492	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—ITGA2B—coronary artery disease	0.000341	0.00115	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—DVL1—coronary artery disease	0.000341	0.00115	CbGpPWpGaD
Nafarelin—Vomiting—Simvastatin—coronary artery disease	0.000341	0.00049	CcSEcCtD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—coronary artery disease	0.000341	0.00115	CbGpPWpGaD
Nafarelin—Nausea—Lovastatin—coronary artery disease	0.00034	0.000489	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—POMC—coronary artery disease	0.00034	0.00114	CbGpPWpGaD
Nafarelin—Hyperhidrosis—Ramipril—coronary artery disease	0.000339	0.000488	CcSEcCtD
Nafarelin—Rash—Simvastatin—coronary artery disease	0.000338	0.000486	CcSEcCtD
Nafarelin—Dermatitis—Simvastatin—coronary artery disease	0.000338	0.000485	CcSEcCtD
Nafarelin—Asthenia—Trandolapril—coronary artery disease	0.000338	0.000485	CcSEcCtD
Nafarelin—Shock—Timolol—coronary artery disease	0.000338	0.000485	CcSEcCtD
Nafarelin—Urticaria—Furosemide—coronary artery disease	0.000337	0.000484	CcSEcCtD
Nafarelin—Diarrhoea—Niacin—coronary artery disease	0.000337	0.000484	CcSEcCtD
Nafarelin—Asthenia—Enalapril—coronary artery disease	0.000336	0.000483	CcSEcCtD
Nafarelin—Headache—Simvastatin—coronary artery disease	0.000336	0.000482	CcSEcCtD
Nafarelin—Dizziness—Valsartan—coronary artery disease	0.000335	0.000481	CcSEcCtD
Nafarelin—Anorexia—Ramipril—coronary artery disease	0.000335	0.000481	CcSEcCtD
Nafarelin—Nausea—Ezetimibe—coronary artery disease	0.000334	0.00048	CcSEcCtD
Nafarelin—Dizziness—Olmesartan—coronary artery disease	0.000333	0.000479	CcSEcCtD
Nafarelin—Pruritus—Trandolapril—coronary artery disease	0.000333	0.000478	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CCL2—coronary artery disease	0.000332	0.00112	CbGpPWpGaD
Nafarelin—Chest pain—Lisinopril—coronary artery disease	0.000332	0.000477	CcSEcCtD
Nafarelin—Myalgia—Lisinopril—coronary artery disease	0.000332	0.000477	CcSEcCtD
Nafarelin—Arthralgia—Lisinopril—coronary artery disease	0.000332	0.000477	CcSEcCtD
Nafarelin—Hyperhidrosis—Timolol—coronary artery disease	0.000332	0.000477	CcSEcCtD
Nafarelin—Asthenia—Telmisartan—coronary artery disease	0.000332	0.000477	CcSEcCtD
Nafarelin—Pruritus—Enalapril—coronary artery disease	0.000332	0.000476	CcSEcCtD
Nafarelin—Diarrhoea—Pravastatin—coronary artery disease	0.000332	0.000476	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCL4—coronary artery disease	0.000331	0.00112	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—OPRD1—coronary artery disease	0.000331	0.00112	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GHR—coronary artery disease	0.000331	0.00112	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—PIK3CA—coronary artery disease	0.00033	0.00111	CbGpPWpGaD
Nafarelin—Anorexia—Timolol—coronary artery disease	0.000327	0.00047	CcSEcCtD
Nafarelin—Pruritus—Telmisartan—coronary artery disease	0.000327	0.00047	CcSEcCtD
Nafarelin—Nausea—Eplerenone—coronary artery disease	0.000327	0.000469	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—KNG1—coronary artery disease	0.000326	0.0011	CbGpPWpGaD
Nafarelin—Dizziness—Niacin—coronary artery disease	0.000325	0.000468	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—BDKRB2—coronary artery disease	0.000325	0.0011	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CXCL12—coronary artery disease	0.000325	0.0011	CbGpPWpGaD
Nafarelin—Urticaria—Losartan—coronary artery disease	0.000325	0.000467	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—AGTR1—coronary artery disease	0.000324	0.00109	CbGpPWpGaD
Nafarelin—Asthenia—Captopril—coronary artery disease	0.000323	0.000463	CcSEcCtD
Nafarelin—Diarrhoea—Trandolapril—coronary artery disease	0.000322	0.000463	CcSEcCtD
Nafarelin—Vomiting—Valsartan—coronary artery disease	0.000322	0.000462	CcSEcCtD
Nafarelin—Diarrhoea—Enalapril—coronary artery disease	0.000321	0.000461	CcSEcCtD
Nafarelin—Dizziness—Pravastatin—coronary artery disease	0.00032	0.00046	CcSEcCtD
Nafarelin—Vomiting—Olmesartan—coronary artery disease	0.00032	0.00046	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.00032	0.00046	CcSEcCtD
Nafarelin—Rash—Valsartan—coronary artery disease	0.000319	0.000459	CcSEcCtD
Nafarelin—Dermatitis—Valsartan—coronary artery disease	0.000319	0.000458	CcSEcCtD
Nafarelin—Nausea—Simvastatin—coronary artery disease	0.000318	0.000457	CcSEcCtD
Nafarelin—Oedema—Lisinopril—coronary artery disease	0.000318	0.000457	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—PLCB1—coronary artery disease	0.000318	0.00107	CbGpPWpGaD
Nafarelin—Pruritus—Captopril—coronary artery disease	0.000318	0.000457	CcSEcCtD
Nafarelin—Rash—Olmesartan—coronary artery disease	0.000318	0.000456	CcSEcCtD
Nafarelin—Insomnia—Ramipril—coronary artery disease	0.000318	0.000456	CcSEcCtD
Nafarelin—Dermatitis—Olmesartan—coronary artery disease	0.000317	0.000456	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—MEF2A—coronary artery disease	0.000317	0.00107	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TLE4—coronary artery disease	0.000317	0.00107	CbGpPWpGaD
Nafarelin—Headache—Valsartan—coronary artery disease	0.000317	0.000456	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL10—coronary artery disease	0.000317	0.00107	CbGpPWpGaD
Nafarelin—Diarrhoea—Telmisartan—coronary artery disease	0.000316	0.000454	CcSEcCtD
Nafarelin—Headache—Olmesartan—coronary artery disease	0.000316	0.000453	CcSEcCtD
Nafarelin—Paraesthesia—Ramipril—coronary artery disease	0.000315	0.000453	CcSEcCtD
Nafarelin—Shock—Lisinopril—coronary artery disease	0.000313	0.00045	CcSEcCtD
Nafarelin—Asthenia—Perindopril—coronary artery disease	0.000313	0.00045	CcSEcCtD
Nafarelin—Dyspnoea—Ramipril—coronary artery disease	0.000313	0.00045	CcSEcCtD
Nafarelin—Vomiting—Niacin—coronary artery disease	0.000313	0.00045	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000313	0.000449	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—HTR7—coronary artery disease	0.000312	0.00105	CbGpPWpGaD
Nafarelin—Dizziness—Trandolapril—coronary artery disease	0.000311	0.000447	CcSEcCtD
Nafarelin—Insomnia—Timolol—coronary artery disease	0.00031	0.000446	CcSEcCtD
Nafarelin—Rash—Niacin—coronary artery disease	0.00031	0.000446	CcSEcCtD
Nafarelin—Dermatitis—Niacin—coronary artery disease	0.00031	0.000445	CcSEcCtD
Nafarelin—Dizziness—Enalapril—coronary artery disease	0.00031	0.000445	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—APOA2—coronary artery disease	0.000309	0.00104	CbGpPWpGaD
Nafarelin—Pruritus—Perindopril—coronary artery disease	0.000309	0.000444	CcSEcCtD
Nafarelin—Headache—Niacin—coronary artery disease	0.000308	0.000443	CcSEcCtD
Nafarelin—Paraesthesia—Timolol—coronary artery disease	0.000308	0.000443	CcSEcCtD
Nafarelin—Vomiting—Pravastatin—coronary artery disease	0.000308	0.000443	CcSEcCtD
Nafarelin—Hyperhidrosis—Lisinopril—coronary artery disease	0.000308	0.000442	CcSEcCtD
Nafarelin—Diarrhoea—Captopril—coronary artery disease	0.000308	0.000442	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—ADRB2—coronary artery disease	0.000307	0.00104	CbGpPWpGaD
Nafarelin—Dyspnoea—Timolol—coronary artery disease	0.000306	0.00044	CcSEcCtD
Nafarelin—Dizziness—Telmisartan—coronary artery disease	0.000306	0.000439	CcSEcCtD
Nafarelin—Rash—Pravastatin—coronary artery disease	0.000306	0.000439	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—AVPR1A—coronary artery disease	0.000305	0.00103	CbGpPWpGaD
Nafarelin—Dermatitis—Pravastatin—coronary artery disease	0.000305	0.000439	CcSEcCtD
Nafarelin—Decreased appetite—Ramipril—coronary artery disease	0.000305	0.000438	CcSEcCtD
Nafarelin—Asthenia—Furosemide—coronary artery disease	0.000304	0.000437	CcSEcCtD
Nafarelin—Headache—Pravastatin—coronary artery disease	0.000304	0.000436	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—PRKCE—coronary artery disease	0.000303	0.00102	CbGpPWpGaD
Nafarelin—Anorexia—Lisinopril—coronary artery disease	0.000303	0.000436	CcSEcCtD
Nafarelin—Nausea—Valsartan—coronary artery disease	0.000301	0.000432	CcSEcCtD
Nafarelin—Pruritus—Furosemide—coronary artery disease	0.0003	0.000431	CcSEcCtD
Nafarelin—Constipation—Ramipril—coronary artery disease	0.0003	0.000431	CcSEcCtD
Nafarelin—Nausea—Olmesartan—coronary artery disease	0.000299	0.00043	CcSEcCtD
Nafarelin—Vomiting—Trandolapril—coronary artery disease	0.000299	0.00043	CcSEcCtD
Nafarelin—Diarrhoea—Perindopril—coronary artery disease	0.000299	0.000429	CcSEcCtD
Nafarelin—Decreased appetite—Timolol—coronary artery disease	0.000298	0.000429	CcSEcCtD
Nafarelin—Vomiting—Enalapril—coronary artery disease	0.000298	0.000428	CcSEcCtD
Nafarelin—Dizziness—Captopril—coronary artery disease	0.000297	0.000427	CcSEcCtD
Nafarelin—Rash—Trandolapril—coronary artery disease	0.000297	0.000426	CcSEcCtD
Nafarelin—Dermatitis—Trandolapril—coronary artery disease	0.000296	0.000426	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—KNG1—coronary artery disease	0.000296	0.000998	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—coronary artery disease	0.000296	0.000996	CbGpPWpGaD
Nafarelin—Rash—Enalapril—coronary artery disease	0.000296	0.000425	CcSEcCtD
Nafarelin—Dermatitis—Enalapril—coronary artery disease	0.000295	0.000424	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—UTS2—coronary artery disease	0.000295	0.000994	CbGpPWpGaD
Nafarelin—Headache—Trandolapril—coronary artery disease	0.000295	0.000424	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—AGTR1—coronary artery disease	0.000294	0.000992	CbGpPWpGaD
Nafarelin—Vomiting—Telmisartan—coronary artery disease	0.000294	0.000422	CcSEcCtD
Nafarelin—Asthenia—Losartan—coronary artery disease	0.000294	0.000422	CcSEcCtD
Nafarelin—Headache—Enalapril—coronary artery disease	0.000294	0.000422	CcSEcCtD
Nafarelin—Nausea—Niacin—coronary artery disease	0.000292	0.00042	CcSEcCtD
Nafarelin—Rash—Telmisartan—coronary artery disease	0.000292	0.000419	CcSEcCtD
Nafarelin—Dermatitis—Telmisartan—coronary artery disease	0.000291	0.000418	CcSEcCtD
Nafarelin—Diarrhoea—Furosemide—coronary artery disease	0.00029	0.000417	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.00029	0.000417	CcSEcCtD
Nafarelin—Pruritus—Losartan—coronary artery disease	0.00029	0.000416	CcSEcCtD
Nafarelin—Headache—Telmisartan—coronary artery disease	0.00029	0.000416	CcSEcCtD
Nafarelin—Dizziness—Perindopril—coronary artery disease	0.000289	0.000415	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—NR4A1—coronary artery disease	0.000289	0.000973	CbGpPWpGaD
Nafarelin—Insomnia—Lisinopril—coronary artery disease	0.000288	0.000414	CcSEcCtD
Nafarelin—Nausea—Pravastatin—coronary artery disease	0.000288	0.000414	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CXCL10—coronary artery disease	0.000288	0.000969	CbGpPWpGaD
Nafarelin—Paraesthesia—Lisinopril—coronary artery disease	0.000286	0.000411	CcSEcCtD
Nafarelin—Vomiting—Captopril—coronary artery disease	0.000286	0.000411	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PLCB3—coronary artery disease	0.000286	0.000963	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—P2RY12—coronary artery disease	0.000286	0.000963	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HDAC9—coronary artery disease	0.000286	0.000963	CbGpPWpGaD
Nafarelin—Dyspnoea—Lisinopril—coronary artery disease	0.000284	0.000408	CcSEcCtD
Nafarelin—Rash—Captopril—coronary artery disease	0.000283	0.000407	CcSEcCtD
Nafarelin—Dermatitis—Captopril—coronary artery disease	0.000283	0.000407	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CX3CR1—coronary artery disease	0.000283	0.000953	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CASR—coronary artery disease	0.000283	0.000953	CbGpPWpGaD
Nafarelin—Headache—Captopril—coronary artery disease	0.000282	0.000405	CcSEcCtD
Nafarelin—Dizziness—Furosemide—coronary artery disease	0.000281	0.000403	CcSEcCtD
Nafarelin—Diarrhoea—Losartan—coronary artery disease	0.00028	0.000402	CcSEcCtD
Nafarelin—Nausea—Trandolapril—coronary artery disease	0.00028	0.000402	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—ADRB2—coronary artery disease	0.000279	0.000941	CbGpPWpGaD
Nafarelin—Urticaria—Ramipril—coronary artery disease	0.000279	0.000401	CcSEcCtD
Nafarelin—Nausea—Enalapril—coronary artery disease	0.000278	0.0004	CcSEcCtD
Nafarelin—Vomiting—Perindopril—coronary artery disease	0.000278	0.000399	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—BDKRB1—coronary artery disease	0.000277	0.000934	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GNA12—coronary artery disease	0.000277	0.000934	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—P4HB—coronary artery disease	0.000277	0.000934	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CX3CL1—coronary artery disease	0.000277	0.000934	CbGpPWpGaD
Nafarelin—Decreased appetite—Lisinopril—coronary artery disease	0.000277	0.000398	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—PRKCE—coronary artery disease	0.000276	0.000929	CbGpPWpGaD
Nafarelin—Rash—Perindopril—coronary artery disease	0.000275	0.000395	CcSEcCtD
Nafarelin—Dermatitis—Perindopril—coronary artery disease	0.000275	0.000395	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—EDN1—coronary artery disease	0.000275	0.000926	CbGpPWpGaD
Nafarelin—Nausea—Telmisartan—coronary artery disease	0.000275	0.000395	CcSEcCtD
Nafarelin—Headache—Perindopril—coronary artery disease	0.000273	0.000393	CcSEcCtD
Nafarelin—Urticaria—Timolol—coronary artery disease	0.000273	0.000392	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CCL5—coronary artery disease	0.000273	0.000919	CbGpPWpGaD
Nafarelin—Constipation—Lisinopril—coronary artery disease	0.000272	0.000391	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PPP3R1—coronary artery disease	0.000272	0.000917	CbGpPWpGaD
Nafarelin—Dizziness—Losartan—coronary artery disease	0.000271	0.000389	CcSEcCtD
Nafarelin—Vomiting—Furosemide—coronary artery disease	0.00027	0.000388	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—ADM—coronary artery disease	0.00027	0.000909	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CSF2—coronary artery disease	0.000268	0.000905	CbGpPWpGaD
Nafarelin—Rash—Furosemide—coronary artery disease	0.000268	0.000384	CcSEcCtD
Nafarelin—Dermatitis—Furosemide—coronary artery disease	0.000267	0.000384	CcSEcCtD
Nafarelin—Nausea—Captopril—coronary artery disease	0.000267	0.000384	CcSEcCtD
Nafarelin—Headache—Furosemide—coronary artery disease	0.000266	0.000382	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PDE4B—coronary artery disease	0.000263	0.000886	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CYBB—coronary artery disease	0.000263	0.000886	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCL8—coronary artery disease	0.000263	0.000885	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—MMP3—coronary artery disease	0.000262	0.000884	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	0.000262	0.000882	CbGpPWpGaD
Nafarelin—Vomiting—Losartan—coronary artery disease	0.00026	0.000374	CcSEcCtD
Nafarelin—Nausea—Perindopril—coronary artery disease	0.000259	0.000372	CcSEcCtD
Nafarelin—Rash—Losartan—coronary artery disease	0.000258	0.000371	CcSEcCtD
Nafarelin—Dermatitis—Losartan—coronary artery disease	0.000258	0.000371	CcSEcCtD
Nafarelin—Headache—Losartan—coronary artery disease	0.000256	0.000368	CcSEcCtD
Nafarelin—Urticaria—Lisinopril—coronary artery disease	0.000253	0.000363	CcSEcCtD
Nafarelin—Nausea—Furosemide—coronary artery disease	0.000252	0.000362	CcSEcCtD
Nafarelin—Asthenia—Ramipril—coronary artery disease	0.000252	0.000362	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—EDN1—coronary artery disease	0.000249	0.000841	CbGpPWpGaD
Nafarelin—Pruritus—Ramipril—coronary artery disease	0.000248	0.000357	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCL5—coronary artery disease	0.000248	0.000834	CbGpPWpGaD
Nafarelin—Asthenia—Timolol—coronary artery disease	0.000246	0.000354	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—PRKCD—coronary artery disease	0.000246	0.000828	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CSF2—coronary artery disease	0.000244	0.000822	CbGpPWpGaD
Nafarelin—Nausea—Losartan—coronary artery disease	0.000243	0.000349	CcSEcCtD
Nafarelin—Pruritus—Timolol—coronary artery disease	0.000243	0.000349	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCR3—coronary artery disease	0.00024	0.00081	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—HTR2A—coronary artery disease	0.00024	0.00081	CbGpPWpGaD
Nafarelin—Diarrhoea—Ramipril—coronary artery disease	0.00024	0.000345	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—C3—coronary artery disease	0.00024	0.000809	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CRK—coronary artery disease	0.000237	0.0008	CbGpPWpGaD
Nafarelin—Diarrhoea—Timolol—coronary artery disease	0.000235	0.000337	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—ATP2A2—coronary artery disease	0.000234	0.00079	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—VWF—coronary artery disease	0.000234	0.00079	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SH2B3—coronary artery disease	0.000234	0.00079	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOC3—coronary artery disease	0.000233	0.000785	CbGpPWpGaD
Nafarelin—Dizziness—Ramipril—coronary artery disease	0.000232	0.000334	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—LDLR—coronary artery disease	0.000231	0.00078	CbGpPWpGaD
Nafarelin—Asthenia—Lisinopril—coronary artery disease	0.000228	0.000328	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—AGT—coronary artery disease	0.000228	0.000768	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PPP2CA—coronary artery disease	0.000227	0.000765	CbGpPWpGaD
Nafarelin—Dizziness—Timolol—coronary artery disease	0.000227	0.000326	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCL3—coronary artery disease	0.000226	0.000762	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCL2—coronary artery disease	0.000226	0.000762	CbGpPWpGaD
Nafarelin—Pruritus—Lisinopril—coronary artery disease	0.000225	0.000324	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—SDC1—coronary artery disease	0.000224	0.000753	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—F2R—coronary artery disease	0.000224	0.000753	CbGpPWpGaD
Nafarelin—Vomiting—Ramipril—coronary artery disease	0.000223	0.000321	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—PRKCD—coronary artery disease	0.000223	0.000751	CbGpPWpGaD
Nafarelin—Rash—Ramipril—coronary artery disease	0.000221	0.000318	CcSEcCtD
Nafarelin—Dermatitis—Ramipril—coronary artery disease	0.000221	0.000318	CcSEcCtD
Nafarelin—Headache—Ramipril—coronary artery disease	0.00022	0.000316	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—FGB—coronary artery disease	0.000219	0.000737	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HTR2A—coronary artery disease	0.000218	0.000735	CbGpPWpGaD
Nafarelin—Vomiting—Timolol—coronary artery disease	0.000218	0.000313	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—C3—coronary artery disease	0.000218	0.000734	CbGpPWpGaD
Nafarelin—Diarrhoea—Lisinopril—coronary artery disease	0.000218	0.000313	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—EDNRB—coronary artery disease	0.000216	0.000729	CbGpPWpGaD
Nafarelin—Rash—Timolol—coronary artery disease	0.000216	0.000311	CcSEcCtD
Nafarelin—Dermatitis—Timolol—coronary artery disease	0.000216	0.000311	CcSEcCtD
Nafarelin—Headache—Timolol—coronary artery disease	0.000215	0.000309	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—THBS1—coronary artery disease	0.000213	0.000719	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PSMA6—coronary artery disease	0.000211	0.000712	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PSMB5—coronary artery disease	0.000211	0.000712	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—F2—coronary artery disease	0.000211	0.00071	CbGpPWpGaD
Nafarelin—Dizziness—Lisinopril—coronary artery disease	0.000211	0.000302	CcSEcCtD
Nafarelin—Nausea—Ramipril—coronary artery disease	0.000209	0.0003	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—AGT—coronary artery disease	0.000207	0.000698	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—EDNRA—coronary artery disease	0.000204	0.000689	CbGpPWpGaD
Nafarelin—Nausea—Timolol—coronary artery disease	0.000204	0.000293	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—ADRB1—coronary artery disease	0.000204	0.000686	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CYBA—coronary artery disease	0.000204	0.000686	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—DUSP6—coronary artery disease	0.000203	0.000683	CbGpPWpGaD
Nafarelin—Vomiting—Lisinopril—coronary artery disease	0.000202	0.000291	CcSEcCtD
Nafarelin—Rash—Lisinopril—coronary artery disease	0.000201	0.000288	CcSEcCtD
Nafarelin—Dermatitis—Lisinopril—coronary artery disease	0.000201	0.000288	CcSEcCtD
Nafarelin—Headache—Lisinopril—coronary artery disease	0.000199	0.000287	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PLAT—coronary artery disease	0.000199	0.000671	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—BDKRB2—coronary artery disease	0.000192	0.000648	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCL12—coronary artery disease	0.000192	0.000648	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—POMC—coronary artery disease	0.000192	0.000647	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—F2—coronary artery disease	0.000191	0.000645	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6ST—coronary artery disease	0.000191	0.000642	CbGpPWpGaD
Nafarelin—Nausea—Lisinopril—coronary artery disease	0.000189	0.000272	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—JUNB—coronary artery disease	0.000189	0.000636	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PLCB1—coronary artery disease	0.000188	0.000633	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HTR7—coronary artery disease	0.000184	0.00062	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ITGAV—coronary artery disease	0.000175	0.000591	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—KNG1—coronary artery disease	0.000175	0.000589	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—POMC—coronary artery disease	0.000174	0.000587	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CREB1—coronary artery disease	0.000174	0.000587	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AGTR1—coronary artery disease	0.000174	0.000586	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL2—coronary artery disease	0.000171	0.000575	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6R—coronary artery disease	0.00017	0.000573	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCL10—coronary artery disease	0.00017	0.000572	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PLG—coronary artery disease	0.000169	0.000571	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ADRB2—coronary artery disease	0.000165	0.000556	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRKCE—coronary artery disease	0.000163	0.000549	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—JAK2—coronary artery disease	0.000163	0.000548	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SOCS1—coronary artery disease	0.000162	0.000547	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—S100B—coronary artery disease	0.000162	0.000546	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SOCS3—coronary artery disease	0.00016	0.000541	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—KITLG—coronary artery disease	0.000159	0.000534	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TGFBR2—coronary artery disease	0.000159	0.000534	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MMP3—coronary artery disease	0.000155	0.000522	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—STAT5A—coronary artery disease	0.000155	0.000522	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOB—coronary artery disease	0.00015	0.000505	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL8—coronary artery disease	0.000148	0.0005	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—JAK2—coronary artery disease	0.000148	0.000498	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—EDN1—coronary artery disease	0.000147	0.000497	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL5—coronary artery disease	0.000146	0.000493	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CSF2—coronary artery disease	0.000144	0.000485	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—FGF1—coronary artery disease	0.000144	0.000485	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—LPL—coronary artery disease	0.000143	0.000482	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MEF2C—coronary artery disease	0.000142	0.000478	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RPS6KB1—coronary artery disease	0.000142	0.000478	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ITGB3—coronary artery disease	0.000138	0.000465	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CXCL8—coronary artery disease	0.000135	0.000454	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PPP2CA—coronary artery disease	0.000134	0.000452	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRKCD—coronary artery disease	0.000132	0.000444	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HTR2A—coronary artery disease	0.000129	0.000434	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—C3—coronary artery disease	0.000129	0.000434	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HIF1A—coronary artery disease	0.000123	0.000414	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AGT—coronary artery disease	0.000122	0.000412	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—LEP—coronary artery disease	0.00012	0.000404	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOE—coronary artery disease	0.00012	0.000404	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOA1—coronary artery disease	0.000118	0.000399	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—KDR—coronary artery disease	0.000117	0.000396	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MAPK14—coronary artery disease	0.000117	0.000393	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ESR1—coronary artery disease	0.000114	0.000386	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—F2—coronary artery disease	0.000113	0.000381	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—FN1—coronary artery disease	0.000113	0.000381	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL6ST—coronary artery disease	0.000113	0.000379	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NFKBIA—coronary artery disease	0.000112	0.000376	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—KIT—coronary artery disease	0.000108	0.000364	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GSK3B—coronary artery disease	0.000104	0.00035	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CREB1—coronary artery disease	0.000103	0.000347	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—POMC—coronary artery disease	0.000103	0.000347	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL2—coronary artery disease	0.000101	0.000339	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL6R—coronary artery disease	0.0001	0.000338	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IGF1—coronary artery disease	9.9e-05	0.000334	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—MAPK1—coronary artery disease	9.86e-05	0.000332	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PIK3CA—coronary artery disease	9.42e-05	0.000317	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SERPINE1—coronary artery disease	9.4e-05	0.000317	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—FGF2—coronary artery disease	9.1e-05	0.000307	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NOS3—coronary artery disease	8.98e-05	0.000303	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—JAK2—coronary artery disease	8.73e-05	0.000294	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PIK3CA—coronary artery disease	8.55e-05	0.000288	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCL8—coronary artery disease	7.96e-05	0.000268	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—AKT1—coronary artery disease	7.69e-05	0.000259	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CASP3—coronary artery disease	7.62e-05	0.000257	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6—coronary artery disease	7.57e-05	0.000255	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCND1—coronary artery disease	7.42e-05	0.00025	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MMP9—coronary artery disease	7.2e-05	0.000243	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AKT1—coronary artery disease	6.99e-05	0.000235	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—VEGFA—coronary artery disease	6.47e-05	0.000218	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TGFB1—coronary artery disease	5.94e-05	0.0002	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MAPK1—coronary artery disease	5.82e-05	0.000196	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PIK3CA—coronary artery disease	5.05e-05	0.00017	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL6—coronary artery disease	4.47e-05	0.000151	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AKT1—coronary artery disease	4.13e-05	0.000139	CbGpPWpGaD
